`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`C.A. No. 18-924-CFC
`
`
`
`GENENTECH, INC.,
`Plaintiff,
`
`v.
`AMGEN INC.,
`
`Defendant.
`
`NOTICE OF SERVICE
`
`
`
`PLEASE TAKE NOTICE that on September 20, 2019, true and correct copies of (1) Expert
`
`Report of Sumanth Addanki, Ph.D.; (2) Reply Expert Report of John A. Glaspy, M.D., M.P.H.
`
`Regarding Secondary Considerations of Nonobviousness; (3) Reply Expert Report of Michael
`
`Glacken, Sc.D.; and (4) Reply Expert Report of Dennis Slamon, M.D., Ph.D. Regarding Secondary
`
`Considerations of Nonobviousness were served via electronic mail on the following counsel:
`
`Michael P. Kelly
`Daniel M. Silver
`Alexandra M. Joyce
`MCCARTER & ENGLISH, LLP
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, DE 19801
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`
`
`
`
`Case 1:18-cv-00924-CFC Document 365 Filed 09/23/19 Page 2 of 2 PageID #: 26809
`
`
`Dated: September 23, 2019
`
`
`
`
`
`
`
`
`SMITH, KATZENSTEIN & JENKINS LLP
`
`
`
`
`/s/ Eve H. Ormerod
`Neal C. Belgam (No. 2721)
`Eve H. Ormerod (No. 5369)
`Jennifer M. Rutter (No. 6200)
`1000 West Street, Suite 1501
`Wilmington, DE 19801
`(302) 652-8400
`nbelgam@skjlaw.com
`eormerod@skjlaw.com
`jrutter@skjlaw.com
`
`Attorneys for Defendant Amgen Inc.
`
`2
`
`